Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial
Circulation · 10.06.2025 · 151 (23) · 1630-1638
DOI: 10.1161/circulationaha.125.074536 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 10.06.2025. Verfasst von Saibal Kar und 26 weiteren Autor:innen. Beteiligte Einrichtung: Los Robles Regional Medical Center, Thousand Oaks, CA (S. Kar, A.A.G.). Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Cardiac Catheterization, Tricuspid Valve, Heart Valve Prosthesis Implantation. Die Arbeit wurde bisher 177-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Abbott Laboratories.
Abstract (Originalsprache)
BACKGROUND: One-year outcomes of TRILUMINATE Pivotal (Trial to Evaluate Cardiovascular Outcomes in Patients Treated With the Tricuspid Valve Repair System Pivotal) found that transcatheter edge-to-edge repair (TEER) for the treatment of severe, symptomatic tricuspid regurgitation improved quality of life compared with medical therapy alone with similar rates of mortality and heart failure hospitalization. However, additional follow-up is necessary to determine the prolonged benefits of tricuspid TEER. METHODS: A total of 572 patients with severe, symptomatic tricuspid regurgitation were randomized to either tricuspid TEER+medical therapy (device group) or medical therapy alone (control). Two-year prespecified end points were recurrent heart failure hospitalization and freedom from all-cause mortality, tricuspid valve surgery, and tricuspid valve intervention after treatment visit, assessed in the intention-to-treat population. RESULTS: The annualized rate of recurrent heart failure hospitalizations through 2 years was significantly lower with tricuspid TEER compared with control (0.19 event per patient-year versus 0.26 event per patient-year; P =0.02; joint frailty model hazard ratio, 0.72; one-sided upper confidence limit, 0.93; P =0.02). Freedom from all-cause mortality, tricuspid valve surgery, and tricuspid valve intervention through 2 years was significantly higher with tricuspid TEER compared with control (77.6% versus 29.3%; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Los Robles Regional Medical Center, Thousand Oaks, CA (S. Kar, A.A.G.).
- Cedars-Sinai Medical Center, Los Angeles, CA (R.R.M.).
- Intermountain Health, Murray, UT (B.K.W.).
- Allina Health Abbott Northwestern Hospital, Minneapolis, MN (N.H., P.S.).
- Integrated Medical Services, Phoenix, AZ (H.N.).
- University of Kansas Medical Center, Kansas City (P.T.).
ORCID-Profile: Saibal Kar, Brian K Whisenant, Matthew J Price, Gagan Singh, Samir Kapadia, Oluseun Alli, Puvi Seshiah, Wayne Batchelor, Brandon M Jones, Mustafa I Ahmed, Raymond Benza, Ulrich Jorde, Gilbert H L Tang, Rebecca T Hahn, Paul Sorajja
Förderung
- Abbott Laboratories
Zitieren
APA
Kar, S., Makkar, R. R., Whisenant, B. K., Hamid, N., Naik, H., Tadros, P., Price, M. J., Singh, G., Schwartz, J. G., Kapadia, S., Alli, O., Horr, S., Seshiah, P., Batchelor, W., Jones, B. M., Ahmed, M. I., Benza, R., Jorde, U., Thourani, V. H., …, & TRILUMINATE Pivotal Investigators (2025). Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial. Circulation, 151(23), 1630-1638. https://doi.org/10.1161/circulationaha.125.074536
Vancouver
Kar S, Makkar RR, Whisenant BK, Hamid N, Naik H, Tadros P, et al. Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial. Circulation. 2025;151(23):1630-1638. doi:10.1161/circulationaha.125.074536
BibTeX
@article{Kar2025,
author = {Kar, Saibal and Makkar, Raj R and Whisenant, Brian K and Hamid, Nadira and Naik, Hursh and Tadros, Peter and Price, Matthew J and Singh, Gagan and Schwartz, Jonathan G and Kapadia, Samir and Alli, Oluseun and Horr, Samuel and Seshiah, Puvi and Batchelor, Wayne and Jones, Brandon M and Ahmed, Mustafa I and Benza, Raymond and Jorde, Ulrich and Thourani, Vinod H and Ghobrial, Andrew A and Tang, Gilbert H L and Trusty, Phillip M and Huang, Dina and Hahn, Rebecca T and Adams, David H and Sorajja, Paul and TRILUMINATE Pivotal Investigators, TRILUMINATE Pivotal Investigators},
title = {Two-Year Outcomes of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation: The TRILUMINATE Pivotal Randomized Controlled Trial},
journal = {Circulation},
year = {2025},
volume = {151},
number = {23},
pages = {1630--1638},
doi = {10.1161/circulationaha.125.074536}
}
EUVIMED